or Try an Advanced Search...

    Technical Analysis for IGMS - IGM Biosciences, Inc.

    Grade Last Price % Change Price Change
    C 11.18 -7.60% -0.92
    IGMS closed down 7.6 percent on Friday, July 26, 2024, on approximately normal volume.
    Earnings due: Aug 1
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical IGMS trend table...
    Date Alert Name Type % Chg
    Slingshot Bullish Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Shooting Star Candlestick Bearish -7.60%
    Lizard Bearish Bearish Day Trade Setup -7.60%
    Calm After Storm Range Contraction -7.60%
    Doji - Bearish? Reversal -7.60%
    Stochastic Reached Overbought Strength -7.60%
    Wide Bands Range Expansion -7.60%
    Overbought Stochastic Strength -7.60%
    Upper Bollinger Band Touch Strength -7.60%
    Older End-of-Day Signals for IGMS ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 10 hours ago
    Fell Below 10 DMA about 10 hours ago
    10 DMA Support about 10 hours ago
    Down 5% about 13 hours ago
    Down 3% about 13 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    IGMS Chart by TradingView
    Basic chart:

    Profile

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Immunology Antibodies Treatment Of Cancer Glycoproteins Biochemistry Protein Engineering Immunoglobulin M

    Is IGMS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 12 IGM Biosciences (IGMS) Soars 32.7%: Is Further Upside Left in the Stock?
    Jun 5 Shareholders May Find It Hard To Justify Increasing IGM Biosciences, Inc.'s (NASDAQ:IGMS) CEO Compensation For Now
    May 30 We're Keeping An Eye On IGM Biosciences' (NASDAQ:IGMS) Cash Burn Rate
    May 29 IGM Biosciences to Present at the Jefferies Healthcare Conference
    May 22 IGM Biosciences up 40% following Biogen HI-Bio buy
    May 12 IGM Biosciences: Unlikely To Move The Needle Again In 2024
    May 10 IGM Biosciences Inc (IGMS) Q1 2024 Earnings: Aligns with EPS Projections Amidst Clinical ...
    May 9 IGM Biosciences GAAP EPS of -$0.83 misses by $0.01, revenue of $0.5M misses by $0.28M
    May 8 IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates
    May 8 IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
    See more IGMS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.7
    52 Week Low 3.81
    Average Volume 398,143
    200-Day Moving Average 8.76
    50-Day Moving Average 8.66
    20-Day Moving Average 9.29
    10-Day Moving Average 11.30
    Average True Range 1.33
    RSI (14) 60.32
    ADX 32.61
    +DI 32.15
    -DI 14.59
    Chandelier Exit (Long, 3 ATRs) 10.39
    Chandelier Exit (Short, 3 ATRs) 10.16
    Upper Bollinger Bands 13.72
    Lower Bollinger Band 4.86
    Percent B (%b) 0.71
    BandWidth 95.45
    MACD Line 1.07
    MACD Signal Line 0.80
    MACD Histogram 0.2714
    Fundamentals Value
    Market Cap 367.75 Million
    Num Shares 32.9 Million
    EPS -4.90
    Price-to-Earnings (P/E) Ratio -2.28
    Price-to-Sales 408.54
    Price-to-Book 3.34
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 13.15
    Resistance 3 (R3) 13.28 12.77 12.82
    Resistance 2 (R2) 12.77 12.27 12.70 12.71
    Resistance 1 (R1) 11.97 11.96 11.72 11.84 12.60
    Pivot Point 11.46 11.46 11.33 11.39 11.46
    Support 1 (S1) 10.66 10.96 10.41 10.53 9.76
    Support 2 (S2) 10.15 10.65 10.08 9.65
    Support 3 (S3) 9.35 10.15 9.54
    Support 4 (S4) 9.22